RecruitingNCT05825911

Evaluation of Diagnostic Accuracy of MCG(Magnetocardiography) Scan in Suspected Coronary Artery Disease

Evaluation of Diagnostic Accuracy of MCG Scan in Suspected Coronary Artery Disease


Sponsor

AMCG

Enrollment

908 participants

Start Date

Jun 24, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This multicenter clinical trial is designed to evaluate the diagnostic accuracy of MCG scan in detecting significant CAD compared to the reference standard CAG.


Eligibility

Min Age: 19 YearsMax Age: 80 Years

Inclusion Criteria3

  • Over 19 years of age at the time of enrollment
  • Patient presenting for CAG
  • Consents to having an MCG scan study

Exclusion Criteria5

  • Patients unable to fit into MCG scan device
  • Patients with implanted cardiac pacemakers/defibrillators
  • Atrial fibrillation with rapid ventricular response
  • Patients with other sustained or incessant arrhythmias
  • Presence clinical suspicious of any acute coronary syndrome

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTRest/Stress MCG scan

All patients enrolled and receiving standard screening tests for CAD will undergo rest/stress MCG scan before CAG.

DIAGNOSTIC_TESTRest MCG scan

This is an normal adult population with age-, and sex-matched control group. All participants enrolled will undergo rest MCG scan.


Locations(2)

The Catholic University of Korea, Eunpyeong St. Mary's Hospital

Seoul, Eunpyeong-gu, South Korea

Gachon University Gil Medical Center

Incheon, Namdong-gu, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05825911


Related Trials